Statement 16 Oct 2024

WHO EMRO RC71: Promoting collaborative action to accelerate the response to antimicrobial resistance in the Eastern Mediterranean Region

On 16 October 2024 in Doha, Qatar, IFPMA delivered a statement at the 71st session of the WHO EMRO Regional Committee on Promoting collaborative action to accelerate the response to antimicrobial resistance in the Eastern Mediterranean Region.

Expert insight 16 Oct 2024

Celebrating a decade of ethical collaboration: An international consensus of healthcare leaders looks to the future

Ten years ago, global health leaders came together to agree the first-of-its-kind international Consensus Framework for ethical collaboration between patients’ organizations, healthcare professionals, and the pharmaceutical industry in support of quality patient care. Since then, the Framework has been adopted across countries worldwide and embedded in international initiatives. This Global Ethics Day, under the theme...

Statement 14 Oct 2024

WHO EMRO RC71: Regional flagship initiative 1: Expanding equitable access to medical products

On 14 October 2024 in Doha, Qatar, IFPMA delivered a statement at the 71st session of the WHO EMRO Regional Committee on the Regional flagship initiative 1: Expanding equitable access to medical products.

Statement 9 Oct 2024

77th WHO SEARO Regional Committee: Agenda items 8.2 and 9.6 on NCDs and UHC

On 9 October 2024 in New Delhi, India, IFPMA delivered a statement at the 77th WHO SEARO Regional Committee on Agenda items 8.2 and 9.6: NCDs and UHC.

Statement 3 Oct 2024

61st PAHO Directing Council: Access and rational use of strategic and high-cost medicines and other health technologies

On 3 October 2024 in Washington, D.C., IFPMA and FIFARMA delivered a statement at the 61st PAHO Directing Council on a report focused on access and rational use of strategic and high-cost medicines and other health technologies.

Statement 3 Oct 2024

61st Directing Council of PAHO: Strategy on epidemic intelligence for strengthening early warning of health emergencies 2024-2029

On 3 October 2024, IFPMA and FIFARMA delivered a statement at the 61st Directing Council of the Pan American Health Organization (PAHO): Strategy on epidemic intelligence for strengthening early warning of health emergencies 2024-2029.

Statement 26 Sep 2024

Statement from IFPMA at UN HLM on AMR 2024

On 26 September 2024, IFPMA submitted the following statement from the floor at the UN High-Level Meeting on AMR. Eight years after the first ever AMR high-level meeting we find ourselves at the precipice of turning the tide. The pharmaceutical industry heard the call to action at the first high-level meeting, and through establishing the...

Expert insight 20 Sep 2024

A framework for trust and global solidarity for the next pandemic

Diplomats from around the world are convening again in Geneva to finalize marathon negotiations set up in 2021, to agree a new global framework that seeks to govern the global response to future pandemics. The stakes couldn’t be higher. This framework will set out how international collaboration will take place to prevent, prepare and respond...

Expert insight 19 Sep 2024

How empowering healthcare professional voices can build public trust and vaccine uptake

To resuscitate public trust in vaccines and recover immunization rates we must change the way we communicate public health. A global program is blueprinting a way forward, starting with healthcare professionals. The COVID-19 pandemic and accompanying infodemic, in which widespread proliferation of disinformation overwhelmed people with misleading information, exposed major deficiencies in public health communications...

Statement 16 Sep 2024

Innovative pharmaceutical industry leaders reinforce ethics and business integrity in APEC economies and health sectors

IFPMA, with support and representation from industry leaders, joins stakeholders this week at the 11th Business Ethics for APEC SMEs Forum. This Forum – and the initiative on which it is based – supports the advancement of ethical business practices in the Asia-Pacific economies, with a focus on the health sector and wider health ecosystem....

External study 12 Sep 2024

The value of prevention for economic growth and the sustainability of healthcare, social care and welfare systems (The European House – Ambrosetti)

Over the last decade, the EU economy has experienced slow growth, and it is not expected to grow substantially in the coming years. Additionally, the ongoing demographic and epidemiological transition is increasing pressure on public finances, particularly healthcare and social expenditure. The current permacrisis – encompassing geopolitical and climate-related challenges – exacerbates these issues and...

Press release 12 Sep 2024

Only an urgent shift towards prevention-based healthcare can secure economic stability for EU health systems, experts say

As Governments of EU Member States present their medium-term fiscal structural plans on 20 September, a new report developed by The European House – Ambrosetti, supported by IFPMA and Vaccines Europe, notes that embedding preventative healthcare – in particular immunisation – into EU Member States’ fiscal policies is paramount to ensure the economic sustainability of...